Precision BioSciences to Present at Upcoming Virtual Investor Conferences in September

Rhea-AI Summary

Precision BioSciences (Nasdaq: DTIL) announced its participation in three upcoming investor conferences, showcasing its ARCUS® genome editing platform. The schedule includes the Wells Fargo Virtual Healthcare Conference on September 10, 2020, at 12:40 PM ET, the H.C. Wainwright Annual Global Investment Conference on September 14, 2020, at 1:30 PM ET, and the Morgan Stanley Global Healthcare Conference on September 17, 2020, at 8:45 AM ET. Live webcasts will be available on the company’s website, with replays accessible for 30 days.

DURHAM, N.C., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS^® genome editing platform, today announced its participation in the following upcoming investor conferences:

• 2020 Wells Fargo Virtual Healthcare Conference
  Date: Thursday, September 10, 2020
  Time: 12:40 – 1:10 PM ET
  
  
• H.C. Wainwright Annual Global Investment Conference
  Date: Monday, September 14, 2020
  Time: 1:30 – 1:50 PM ET
   
• Morgan Stanley Global Healthcare Conference
  Date: Thursday, September 17, 2020
  Time: 8:45 – 9:15 AM ET

Live webcasts of each presentation will be accessible on the Company’s website, www.PrecisionBiosciences.com, under the Investors & Media section. An archived replay of the webcasts will be available for approximately 30 days following the presentations.

About Precision BioSciences, Inc.
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS^® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company’s pipeline consists of multiple “off-the-shelf” CAR T immunotherapy clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist. Elo Life Systems is a wholly-owned subsidiary of Precision BioSciences also using ARCUS to benefit human health and wellness with novel food products that enhance the nutrition and diversity of global food supply. For more information about Precision BioSciences please visit www.precisionbiosciences.com.

Contact:
Maurissa Messier
Senior Director, Corporate Communications
Maurissa.messier@precisionbiosciences.com

Josh Rappaport
Stern Investor Relations
josh.rappaport@sternir.com

FAQ

What investor conferences is Precision BioSciences participating in September 2020?

Precision BioSciences is participating in the Wells Fargo Virtual Healthcare Conference on September 10, the H.C. Wainwright Annual Global Investment Conference on September 14, and the Morgan Stanley Global Healthcare Conference on September 17, 2020.

What time is the Wells Fargo Virtual Healthcare Conference presentation?

The Wells Fargo Virtual Healthcare Conference presentation is scheduled for September 10, 2020, at 12:40 PM ET.

Where can I watch the live presentations by Precision BioSciences?

The live presentations by Precision BioSciences can be watched on their website under the Investors & Media section.

How long will the archived webcasts of the Precision BioSciences conferences be available?

The archived webcasts of the Precision BioSciences conferences will be available for approximately 30 days following the presentations.

What is Precision BioSciences' focus in biotechnology?

Precision BioSciences is dedicated to improving life through its ARCUS® genome editing platform, which aims to address genetic and infectious diseases.